Literature DB >> 9350094

Audit of the implementation of selective neonatal BCG immunisation in south east London.

E Tseng1, A Nesbitt, D O'Sullivan.   

Abstract

The implementation of a selective neonatal BCG immunisation policy adopted in south east London boroughs of Lambeth, Southwark, and Lewisham in 1992 has been audited. A survey conducted 18 months after the policy was implemented showed that only 11% of infants identified as eligible for neonatal BCG immunisation had been immunised. The results of the survey were fed back to neonatal units, which were encouraged to improve access to BCG immunisations for eligible infants. A second survey 17 months later showed that 14% of eligible infants had been immunised. Difficulties in applying complex selection criteria, rapid turnover of trained staff in acute units, and short neonatal stay were thought to contribute to the poor uptake of the selective programme delivered in the neonatal units. A community based BCG immunisation service has been commissioned to improve uptake.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9350094

Source DB:  PubMed          Journal:  Commun Dis Rep CDR Rev        ISSN: 1350-9349


  4 in total

Review 1.  Audit and risk management in community child health.

Authors:  D M B Hall; T H J Matthews
Journal:  Arch Dis Child       Date:  2002-08       Impact factor: 3.791

Review 2.  Does BCG have a role in tuberculosis control and prevention in the United Kingdom?

Authors:  S S S Teo; D V Shingadia
Journal:  Arch Dis Child       Date:  2006-06       Impact factor: 3.791

3.  Ethnic differences in the rates of BCG vaccination.

Authors:  S A Deshpande
Journal:  Arch Dis Child       Date:  2004-01       Impact factor: 3.791

4.  BCG vaccination in England since 2005: a survey of policy and practice.

Authors:  Daniel Pilger; Patrick Nguipdop-Djomo; Ibrahim Abubakar; David Elliman; Laura C Rodrigues; John M Watson; Vera Eastman; Punam Mangtani
Journal:  BMJ Open       Date:  2012-09-10       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.